United States Copper Index Fund vs McKesson Corporation — how do they compare? United States Copper Index Fund trades at $38.39, while McKesson Corporation trades at $801.98 (market cap $94.06B). The key difference: McKesson Corporation pays a 0.41% dividend while United States Copper Index Fund pays none, and United States Copper Index Fund is trading nearer its 52-week high, McKesson Corporation nearer its low. Which is the better fit depends on your goals.
| CPER | MCK | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $40.60 | $995.69 |
52-Week Low | $27.21 | $659.01 |
Market Cap | — | $94.06B |
Enterprise Value | — | $98.70B |
Dividend Yield | — | 0.41% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
McKesson (MCK) trades at $812.28, up 0.78% with a bullish technical signal. The stock shows consistent earnings beats, with Q1 2026 EPS of $11.69 exceeding expectations. Revenue grew to $359.05B in 2025, though net margins remain thin at 1.18%. Analysts maintain strong buy consensus (80%) with a $932.83 price target. Recent news highlights growth in specialty pharma and oncology services, supporting positive momentum.
Outlook remains positive driven by earnings strength and sector tailwinds, but risks include policy changes and high liabilities. The stock offers value with a P/E of 21.16 and P/S of 0.25, though investors should monitor debt levels and execution risks amid competitive pressures.
Trailing returns across standard periods
Latest headlines on both assets
CPER is a commodity ETF that tracks the price of copper futures via the SummerHaven Copper Index. It provides direct exposure to the 'red metal' using a rules-based strategy to select futures contracts, making it a key tool for hedging or betting on industrial growth and electrification.
Read more on CPER →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →